Recent Submissions

  • Podocyte infolding glomerulopathy masquerading as membranous nephropathy - a shared pathogenesis?

    Matthai, Smita Mary; Hems, Liam; Tsang, Yee Wah; Aggarwal, Yogita; Mahmoud, Huda; Gopalakrishnan, Kishore; Mahmoud, Huda; Nephrology; Medical and Dental; Christian Medical College; University Hospitals Coventry and Warwickshire NHS Trust; Walsall Healthcare NHS Trust (Medknow Publications, 2024-08-01)
    Podocyte infolding glomerulopathy (PIG) is a rare pathological entity, diagnosed by electron microscopic demonstration of diffuse infolding of the podocytes into the glomerular basement membranes. We report the first case from United Kingdom exhibiting typical ultrastructural features of PIG in a male with Type II diabetes mellitus, hypertension and common variable immune deficiency. Renal biopsy revealed phospholipase A2 receptor (PLA2R) immunostain positive membranous nephropathy (MN) but no serum PLA2R antibodies. Diffuse infolding of the podocytes into the glomerular basement membranes along with pathognomonic microspherular and microtubular intra basement membrane clusters distributed diffusely and globally were noted on electron microscopy, diagnostic of PIG. We postulate a shared pathomechanistic link between PIG and MN, highlighting the overlapping features of both conditions.
  • Multiparametric renal magnetic resonance imaging for prediction and annual monitoring of the progression of chronic kidney disease over two years

    Buchanan, Charlotte E; Mahmoud, Huda; Cox, Eleanor F; Prestwich, Benjamin L; Noble, Rebecca A; Selby, Nicholas M; Taal, Maarten W; Francis, Susan T; Mahmoud, Huda; Nephrology; et al. (MDPI, 2023-11-24)
    Background: Multiparametric renal Magnetic Resonance Imaging (MRI) provides a non-invasive method to assess kidney structure and function, but longitudinal studies are limited. Methods: A total of 22 patients with CKD category G3-4 (estimated glomerular filtration rate (eGFR) 15-59 mL/min/1.73 m2) were recruited. Annual 3T multiparametric renal MRI scans were performed, comprising total kidney volume (TKV), longitudinal relaxation time (T1), apparent diffusion coefficient (ADC), Arterial Spin Labelling, and Blood Oxygen Level Dependent relaxation time (T2*), with 15 patients completing a Year 2 scan. CKD progression over 2 years was defined as eGFR_slope ≥ -5 mL/min/1.73 m2/year. Results: At baseline, T1 was higher (cortex p = 0.05, medulla p = 0.03) and cortex perfusion lower (p = 0.015) in participants with subsequent progression versus stable eGFR. A significant decrease in TKV and ADC and an increase in cortex T1 occurred in progressors at Year 1 and Year 2, with a significant decrease in perfusion in progressors only at Year 2. The only decline in the stable group was a reduction in TKV. There was no significant change in cortex or medulla T2* at Year 1 or Year 2 for progressors or stable participants. Conclusion: Lower renal cortex perfusion and higher T1 in the cortex and medulla may predict CKD progression, while renal cortex T1, TKV, and ADC may be useful to monitor progression. This study provides pilot data for future large-scale studies.
  • Impact of low-protein diet on cardiovascular risk factors and kidney function in diabetic nephropathy : a systematic review and meta-analysis of randomized-controlled trials

    Sohouli, Mohammad Hassan; Mirmiran, Parvin; Seraj, Shaikh Sanjid; Kutbi, Emad; Alkahmous, Hadil Ali Mohammed; Almuqayyid, Faisal; Arafah, Omar Ahnaf; Barakeh, Abdul Rahman Riad; Abu-Zaid, Ahmed; Seraj, Shaikh Sanjid; et al. (Elsevier, 2022-09-06)
    Aim: To assess the efficacy of low-protein diets (LPD) on cardiovascular risk factors and kidney function in diabetic nephropathy (DN) based on randomized controlled trials (RCTs). Methods: A comprehensive systematic search was undertaken in PubMed/MEDLINE, Web of Science, SCOPUS and Embase databases from inception until January 2022 without using time or language restrictions. RCTs which reported the effects of LPD on cardiovascular risk factors and kidney function in DN were considered. Results: The results of the present study showed that a LPD significantly reduces urinary urea (WMD: -244.49 g/day, 95 % CI: -418.83, -70.16, P = 0.006) and HbA1c (WMD: -0.20, 95 % CI: -0.39, -0.01, P = 0.036) levels. However, the results did not show neither significant nor beneficial effect on other renal function and cardiovascular risk factors. Furthermore, the results of subgroup analysis showed LPD caused a further decrease in HbA1c during the follow-up period of ≤ 24 weeks, protein intake less than 0.8 g/kg/d and in individuals younger than 50 years. Albuminuria also showed a greater reduction in people under the age of 50 with type 1 diabetes (DMT1) following a LPD. Conclusion: The results of the present study showed that LPD significantly reduces urinary urea and HbA1c.
  • Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis

    Ali, Hatem; Daoud, Ahmed; Mohamed, Mahmoud M; Salim, Sohail Abdul; Yessayan, Lenar; Baharani, Jyoti; Murtaza, Asam; Rao, Vinaya; Soliman, Karim M; Murtaza, Asam; et al. (Taylor and Francis Group, 2020-11)
    A systematic review and meta-analysis looking at survival rate in acute kidney injury superimposed COVID-19 patients
  • A role that has transformed the care of patients with acute kidney injury

    Grace, Anne; Grace, Anne; Nephrology; Nursing and Midwifery Registered; Walsall Healthcare NHS Trust (MA Healthcare, 2022)
    Anne Grace, Acute Kidney Injury Specialist Nurse, Walsall Healthcare NHS Trust (anne.grace@walsallhealthcare.nhs.uk), runner-up in the Renal Nurse of the Year category of the BJN Awards 2021.